704-1009

withdrawn

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-08-27

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-17 (study day 22.0); relationship: REMOTE

mild assessed

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-05 (study day 10.0); relationship: REMOTE

mild assessed

Mild MALAISE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-05 (study day 10.0); relationship: POSSIBLE

mild assessed

Mild MALAISE — outcome: RECOVERED/RESOLVED; onset 2013-09-05 (study day 10.0); relationship: POSSIBLE

mild assessed

Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-09-22 (study day 27.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-14 (study day 19.0); relationship: POSSIBLE

Data queries

No data queries.